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The leaves and stems of Perilla frutescens var. acuta Kudo (PF) have been used to prevent threatened
abortion in traditional medicine in the East Asian countries. Because reduced receptivity of endometrium
is a cause of abortion, we analyzed the action of PF on the endometrial receptivity. PF increased the level
of leukemia inhibitory factor (LIF), a major cytokine regulating endometrial receptivity, and LIF receptor
in human endometrial Ishikawa cells. The PF-induced LIF expression was mediated by c-jun N-terminal
kinase (JNK) and p38 pathways. Adhesion between Ishikawa cells and trophoblastic JAr cells stimulated
by PF treatment was abolished by knock down of LIF expression or antagonism of LIFR. In addition, the
expressions of integrin b3 and b5 were increased by PF treatment in Ishikawa cells. The PF-induced
expression of integrin b3 and b5 was reduced with an LIFR antagonist. Neutralization of both integrins
successfully blocked PF-stimulated adhesion of JAr cells and Ishikawa cells. These results suggest that PF
enhanced the adhesion between Ishikawa cells and JAr cells by increasing the expression of integrin b3
and b5 via an LIF-dependent pathway. Given the importance of endometrial receptivity in successful
pregnancy, PF can be a novel and effective candidate for improving pregnancy rate.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
In spite of the development of diverse assisted reproduction
technologies (ARTs), including in vitro fertilization, prevention of
incomplete embryo implantation remains a major unmet need (1).
To solve the problem of embryo implantation, it is crucial to
enhance endometrial receptivity toward a properly developed
embryo (2). It is well known that diverse biomolecules, such as
cytokines and growth factors, play important roles in the process of
developing a receptive endometrium (3). Among them, severale and Healthy Aging Korean
Yangsan, Gyeongsangnam-do
rmacological Society.
g by Elsevier B.V. on behalf of Japa
d/4.0/).previous studies have shown that leukemia inhibitory factor (LIF), a
member of interleukin-6 family of cytokines, is one of the major
factors that regulates endometrial receptivity (4). In addition, LIF
expression defects have been shown to be involved in multiple
implantations failures in patients with female infertility (5).
Therefore, research has focused on developing novel candidates
that stimulate embryo implantation rates by enhancing LIF
expression, especially by using natural herbal medicines or tradi-
tional therapy, including acupuncture (6e8).
The leaves and stems of Perilla frutescens var. acuta Kudo
(Labiatae family), a perennial herb, has being used in traditional
medicine of East Asian countries for treating symptoms of the
common cold, including shivering ﬁts, fever, chest pains, and
cough, and for preventing threatened abortion (9). In addition,
previous pharmacological studies have shown that P. frutescens has
anti-inﬂammatory and anti-tumor effects (10,11). However, therenese Pharmacological Society. This is an open access article under the CC BY-NC-ND
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endometrial receptivity or pregnancy rate. Because reduced
endometrial receptivity is a cause of abortion in early stage of
pregnancy (12), we predicted that PF may be involved in the
regulation of endometrial receptivity.
In this study, we investigated the effect of P. frutescens on the
expression of LIF and adhesion between trophoblast and endome-
trium in vitro. The expression of adhesion molecules, including
integrins involved in PF-induced endometrial receptivity was also
examined.
2. Materials and methods
2.1. Materials
Antibodies against LIF, LIFR, phospho-extracellular signal-regu-
lated kinases (ERK) 1/2, ERK2, p38, integrin aV, b3, and b5, glyc-
eraldehyde 3-phosphate dehydrogenase (GAPDH), and b-actin
were purchased from Santa Cruz Biotechnology (Dallas, TX). Anti-
bodies against phospho-c-Jun N-terminal kinases (JNK) and
phospho-p38 were purchased from Cell signaling (Danver, MA,
USA), and the antibody for JNK was purchased from SigmaeAldrich
(St. Louis, MO, USA). Speciﬁc inhibitors against signaling pathways,
including U0126 (inhibitor for mitogen-extracellular signal-regu-
lated kinase/extracellular signal-regulated kinase; MEK/ERK),
SB203580 (inhibitor for p38), and SP600125 (inhibitor for JNK)
were obtained from Merck Millipore (Billerica, MA, USA). Recom-
binant antagonists for human LIFR (hLA) expressed in Escherichia
coli were prepared as described previously (13).
2.2. Plant material and extract preparation
The leaves and stems of P. frutescens were purchased from
Omniherb Co. (Daegu, Korea). The plant was collected in
Gyeongsangbuk-do Province, Republic of Korea in 2013, and iden-
tiﬁed by a botanical expert working at Omniherb Co. A boucher
specimen (KMRC-DC-H21) was deposited at the Healthy Aging
Korean Medicine Research Center, Pusan National University. The
sample was extracted as previously described (14). Brieﬂy, the
leaves and stems of P. frutescens (100 g) were extracted with
distilled water (1 L) for 2 h at 100 C, and then centrifuged at
4000 rpm for 10 min. The supernatant was extracted with 70%
ethanol for polysaccharide precipitation at 4 C. After centrifuga-
tion at 4000 rpm for 10 min, the supernatant was evaporated and
lyophilized by freeze-drier to give a powder (abbreviated as PF,
7.856 g). PF was freshly dissolved in dimethyl sulfoxide (Sigma-
eAldrich) before experiments.
2.3. Fingerprinting high-performance liquid chromatography
(HPLC) analysis
Phytochemical characteristics of PF were identiﬁed by HPLC
analysis as previously described (9,15), with some modiﬁcations.
HPLC analysis was performed using an Agilent 1200 series system
(Agilent Technologies, Santa Clara, CA, USA) and LC solution soft-
ware (version 1.24) was used for data analysis. AkzoNobel KR100-
5C18 column (AkzoNobel, Amsterdam, Netherlands;
4.6 250 mm; pore size, 3.5 mm) was used as an analytical column.
The mobile phases were solvent A [0.1% formic acid aqueous (v/v)]
and solvent B (methanol). The gradient ﬂow was as follows: (A)/
(B) ¼ 100/0 (5 min)/ (A)/(B) ¼ 50/50 (20 min)/ (A)/(B) ¼ 0/100
(30 min)/ (A)/(B) ¼ 100/0 (5 min). The column temperature was
maintained at 35 C. The analysis was carried out at a ﬂow rate of
1 mL/min with detection at 254 nm. The column injection volume
was 20 mL. A standard solution, containing protocatechuic acid,coumaric acid, ferulic acid, and rosmarinic acid was prepared by
dissolving in distilled water (10 mM). The solution was ﬁltered
through a 0.45 mm membrane ﬁlter before HPLC analysis.
2.4. Cell culture
The human endometrial Ishikawa cell line was generously
provided by Dr. Jacques Simard (CHUL Research Center, Quebec,
Canada) and human trophoblastic JAr cells were provided from the
Korean Cell Line Bank (Seoul, Korea). Ishikawa cells were cultured
as monolayers at 37 C in an atmosphere containing 5% CO2/air and
Dulbecco's Modiﬁed Eagle Medium (DMEM; Welgene, Daegu, Ko-
rea) with 10% heat-inactivated fetal bovine serum (FBS; Sigma-
eAldrich) and 1% penicillin/streptomycin (Gibco, Carlsbad, CA,
USA). JAr cells were cultured as monolayers at 37 C in an atmo-
sphere containing 5% CO2/air and Roswell Park Memorial Institute
1640 (RPMI1640; Welgene) containing 10% heat-inactivated FBS
and 1% penicillin/streptomycin.
2.5. Cell viability assay
Ishikawa cells were cultured in 24-well plateswith the indicated
concentrations of PF in serum free medium for 24 h. Next, the
medium was replaced with 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) solution (2 mg/mL) and incu-
bated at 37 C in a cell culture incubator for 3 h. The formazan
crystals formed by MTT reduction were dissolved with DMSO and
EtOH solution and measured at 540 nm with a microplate reader
(SpectraMax M2, Molecular Devices, Sunnyvale, CA, USA).
2.6. Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was isolated from Ishikawa cells using GeneJET RNA
Puriﬁcation Kit (Thermo Fischer Scientiﬁc, Waltham, MA, USA).
Total RNA of each sample was subjected to reverse transcription
with oligo-dT primers by using M-MLV reverse transcriptase
(Enzynomics, Daejeon, Korea). The cDNA was ampliﬁed by PCR
using DiaStarTM Taq DNA Polymerase (Solgent Co., Daejeon, Korea).
The primers and PCR conditions used for amplifying LIF, b-actin,
ITGAV, ITGB3, and ITGB5 are shown in Table 1. The ampliﬁed DNA
was separated by electrophoresis in 1% agarose gels containing
ethidium bromide and visualized under ultraviolet (UV) light. The
images were acquired with the GelDoc-It TS Imaging System (UVP,
Upland, CA, USA).
2.7. Western blot analysis
Total proteins were isolated from Ishikawa cells. Equal amount
of proteins (25 mg) were separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and electro-
transferred to nitrocellulose membranes (Bio-Rad Laboratories,
Hercules, CA, USA). The membranes were blocked in 5% skim milk
in Tris-buffered saline (TBS) and then incubatedwith each antibody
for target proteins, including LIF, LIFR, phospho-ERK1/2, ERK2,
phospho-p38, p38, phospho-JNK, JNK, integrin aV, integrin b3,
integrin b5, GAPDH, and b-actin, overnight. Membranes were then
washed in TBS and incubated with appropriate secondary anti-
bodies conjugated with the horseradish peroxide. The signals were
visualized by using the enhanced chemiluminescence system (GE
Healthcare, Piscataway, NJ, USA).
2.8. Adhesion assay
Ishikawa cells (1.5  106 cells) were seeded in 6 well plates
overnight. Media were replaced and incubated in serum free-
Table 1
Primers used for PCR of LIF, integrins, and b-actin.


























E.-Y. Kim et al. / Journal of Pharmacological Sciences 131 (2016) 259e266 261DMEMwith the indicated concentration of PF for 48 h. The JAr cells
were labeled with 5-chloromethylﬂuoresceindiacetate (CMFDA)
ﬂuorescence dye (CellTracker Green; Invitrogen, Carlsbad, CA, USA)
for 10 min at 37 C. Then, the labeled JAr cells were washed in
1 phosphate-buffered saline and incubatedwith Ishikawa cells by
gently shaking at room temperature for 30 min. The cells were
vigorously washed to remove non-attached JAr cells. The attached
JAr cells were visualized by using a ﬂuorescence microscope (Axi-
oimager M1 microscope, Zeiss, Aalen, Germany) and the cell
numbers were calculated.2.9. Knockdown of LIF by short hairpin RNA (shRNA)
To knockdown hLIF expression, ﬁve different shRNA clones were
purchased fromOpen Biosystems (Thermo Scientiﬁc). The lentiviral
vector encoding shRNA (3 mg) was transfected in 293Tcells by using
Lipofectamine 2000 (Invitrogen). After 48 h, supernatants
harboring lentiviruses were collected and infected into Ishikawa
cells. The cells were subjected to selectionwith 3 mg/mL puromycin
(SigmaeAldrich) for 1 week. The knockdown efﬁciency of the
shRNAs against LIF expression was checked by western blot
analysis.2.10. Statistical analysis
The data from experiments were indicated as the value of per-
centage compared to the control and expressed as the
mean ± standard deviation (SD). The differences between themean
values of 2 groups were determined by student t-test and multi-
comparisons between groups were analyzed using one-way anal-
ysis of variance (ANOVA) with a Turkey's post-hoc test using
GraphPad Prism (GraphPad Software, La Jolla, CA, USA). The mini-
mum signiﬁcance level was set at a p-value of 0.05. All experiments
were performed at least three times, independently.Fig. 1. HPLC chromatogram and cytotoxic effect of leaves and stems of Perilla
frutescens (PF). (A) HPLC chromatogram was performed by using protocatechuic acid,
coumaric acid, ferulic acid, and rosmarinic acid as standards. (B) Ishikawa cells were
treated with indicated concentrations of PF in serum-free culture medium for 24 h. Cell
viability was estimated by using MTT assay and calculated as means ± SD of three
independent measurements. **p < 0.05 in comparison with control group (1st lane).3. Results
3.1. HPLC analysis and cytotoxic effect of PF on Ishikawa cells
As shown in Fig. 1A, the PF used in this study seems to be
identical to the previously reported PF standard (9,15). To deter-
mine the optimal concentration, the cytotoxic effect of PF on Ishi-
kawa cells was determined. PF did not show signiﬁcant cytotoxicity
up to a concentration of 50 mg/mL (Fig. 1B). Thus, for subsequent
studies, 50 mg/mL was established as the optimum working
concentration.3.2. PF increased the attachment of JAr onto Ishikawa cells and the
expression of LIF and LIFR
To examine the possibility that PF affects implantation of a hu-
man embryo onto the endometrium, we performed an in vitro
adhesion assay using human trophoblastic JAr cells and endome-
trial Ishikawa cells. Adhesion between Ishikawa cells and, JAr cells
E.-Y. Kim et al. / Journal of Pharmacological Sciences 131 (2016) 259e266262was increased about 2 fold in PF treated cells compared to control
(Fig. 2A), indicating that PF has a positive effect on the adhesion
between JAr cells and Ishikawa cells. Because the function of LIF and
the LIFR pathway is crucial in embryo implantation process (16), we
checked the expression level of LIF and LIFR. Result from western
blot and RT-PCR analyses clearly demonstrated that the levels of LIF
and LIFR were increased by PF treatment in a dose-dependent
manner (Fig. 2B and C).3.3. PF regulates LIF expression through activating p38 and JNK
Several previous studies have found that the expression of LIF
was regulated byMAP kinase signaling pathways (17,18). Therefore,
we examined if activation of ERK, JNK, and p38 pathway is involved
in PF-induced expression of LIF. The results showed that PF treat-
ment activated p38 and ERK from 2 h. The JNK was activated after
2 h from treatment of PF (Fig. 3A). In addition, phosphorylation of
ERK, JNK, and p38 were increased in a dose-dependent fashion
(Fig. 3B). To conﬁrm which of these signaling pathways regulated
LIF expression, we used speciﬁc inhibitors for each of these
signaling molecules, such as SP600125 for JNK, SB203580 for p38,
and U0126 for MEK/ERK. The results of RT-PCR and western blot
analysis clearly indicate that treatment of SP600125 and SB202580
signiﬁcantly blocked the PF-induced stimulation of LIF expression
(Fig. 3C). In addition, as shown in Fig. S1 PF-induced increase in LIFR
expression was mediated by JNK, p38, and ERK pathways.Fig. 2. The effect of PF on adhesion between Ishikawa and JAr cells and on the expression
(50 mg/mL) for 48 h. JAr cells labeled with CellTracker were attached onto the Ishikawa cell
calculated as percentage of control and are shown as mean ± SD of three independent exp
treated with indicated concentrations of PF for 24 h. Protein and total RNAwere prepared and
PCR. The expressions of GAPDH and b-actin were used as internal controls. Band intensity
periments. *p < 0.05, **p < 0.01, and ***p < 0.001 in comparison with control group (1st la3.4. PF augments adhesion of JAr cells to Ishikawa cells through the
LIF/LIFR axis
To demonstrate whether ligandereceptor interaction of LIF/LIFR
axis plays an important role in PF-induced adhesion between JAr
and Ishikawa cells, we performed the adhesion assay using
knocking down of LIF expression by shRNA transfection and
antagonizing LIFR by hLA treatment. We found that knocking down
LIF expression in Ishikawa cells abrogated PF-stimulated adhesion
between JAr and Ishikawa cells (Fig. 4A). In addition, pretreatment
with hLA reduced PF-induced adhesion of JAr cells onto Ishikawa
cells (Fig. 4B).
3.5. LIF-dependent expression of integrin b3 and b5 is crucial for
the adhesion of trophoblast on endometrial cells
The expressions of adhesion molecules including integrins,
plays an important roles in the regulation of endometrial recep-
tivity toward properly developed embryos (19,20). To evaluate
which integrins are involved in PF-induced adhesion of trophoblast
on endometrial cells, we examined the expression of integrin aV,
b3, and b5. We found that the expression of integrin b3 and b5 was
increased by PF treatment. The expression of integrin aV was not
changed by PF treatment. The PF-stimulated expression of integrin
b3 and b5 was reduced by suppression of LIFR function using hLA
(Fig. 5A and B). The results demonstrated that PF regulates the
expression of integrin b3 and b5 in an LIF-dependent manner.of LIF and LIFR. (A) Ishikawa cells were cultured in 6-well plates as monolayer with PF
s. The attached cells were ﬁxed and pictured using ﬂuorescent microscopy. Data were
eriments. ***p < 0.001 in comparison between two groups. (B, C) Ishikawa cells were
the expression levels of LIF (B) and LIFR (C) were analyzed by western blotting and RT-
was calculated by fold of control and shown as mean ± SD of three independent ex-
ne).
Fig. 3. Analysis of signal pathways responsible for PF-induced LIF expression in Ishikawa cells. (A, B) The Ishikawa cells were treated with PF (50 mg/mL) for indicated times (A)
or with the indicated concentration of PF for 2 h (B). The phosphorylation of signal molecules was examined by western blot analysis. Band intensity was calculated by fold of
control and shown as mean ± SD of three independent experiments. *p < 0.05, **p < 0.01, and ***p < 0.001 in comparison with control group (1st lane) (C) Ishikawa cells were
pretreated with 5 mM of speciﬁc inhibitors for JNK (SP600125), p38 (SB203580) or ERK (U0126). After 1 h, the cells were treated with PF (50 mg/mL) for 24 h. The protein and mRNA
expression levels of LIF were estimated by Western blot analysis and RT-PCR, respectively. The expression of b-actin was used as the internal control. The intensities of bands were
calculated by fold of control and shown as mean ± SD of three independent experiments. ***p < 0.001 in comparison with control group (1st lane) and ###p < 0.001 in comparison
with PF-treated group (2nd lane).
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b5 plays a crucial role in PF-enhanced endometrial receptivity to-
ward trophoblast. The treatment of neutralization antibodies
against these integrins blocked PF-stimulated attachment of JAr
cells onto Ishikawa cells (Fig. 5C). Thus, we concluded that PF-
induced expression of integrin b3 and b5 plays a key role in the
stimulation of endometrial receptivity.
4. Discussion
Traditional medicine has been used to treat female infertility,
and progressively increased efforts have been made to provide
evidence that supports its use (7,8,21). Diverse cytokines and
growth factors, such as interleukin-1, epidermal growth factor
(EGF), calcitonin, amphiregulin, heparin binding-EGF, colony
stimulating factor-1, trophinin/tastin, and LIF, are involved in em-
bryo implantation (22). Among them, LIF in particular is regardedas a major factor that regulates endometrial receptivity, because
genetic abolishment or functional suppression of LIF impairs em-
bryo implantation (23,24). Thus, we focused on the expression of
LIF as part of our ongoing efforts to identify novel agents that
enhance embryo implantation and improve pregnancy rates. Here,
we demonstrated that PF increases the expression of LIF and im-
proves endometrial receptivity toward trophoblastic cells in vitro.
As there is no standard drug in use that enhances endometrial
receptivity, we were not able to compare our results to reference
drug. However, from this point of view, we believe that treatment
with PF is a promising strategy for overcoming infertility due to
implantation failure.
A well-established in vitro model has been used to investi-
gate endometrial receptivity of several human cell lines with,
diverse characteristics (25). The Ishikawa cell line, a well-
differentiated human endometrial adenocarcinoma, was estab-
lished by Dr. Nishida in 1980, and it has since been used to
Fig. 4. The expression and function of LIF is crucial for PF-induced adhesion between Ishikawa and JAr cells. (A) Ishikawa cells were transfected with pLKO.1 or shLIF, and
treated with PF for 48 h. Adhesion assay were performed using ﬂuorescence labeled-JAr cells, Images were acquired, and attached JAr cells were counted. Data were calculated as
the percentage of control and are represented as the mean ± SD. ***p < 0.001 in comparison between two groups. (B) Ishikawa cells were pre-treated with antagonist for LIF-R for
1 h, and then treated with PF (50 mg/mL). Adhesion assay were performed using ﬂuorescence labeled-JAr cells. Attached JAr cells were counted and calculated as percentage of
control. Data from three independent experiments were shown as mean ± SD. ***p < 0.001 in comparison between two groups.
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trium (26). JAr cells, a choriocarcinoma cell line, also have been
used as trophoblastic cells to examine embryo implantation
(27). Thus, in this study, we chose to use these cells for inves-
tigating the expression of LIF and for evaluating endometrial
receptivity.
The results clearly showed that PF increases in a dose dependent
manner, the expression of not only LIF but also LIFR (Fig. 2). Few
studies have examined the regulation of LIF expression. The in-
duction of LIF by IL-1b is mediated by the MEK/ERK and nuclear
factor kappa B (NF-kB) pathway in normal articular human chon-
drocytes (28). In addition, it is known that the p38 MAPK signaling
pathway is activated upstream of LIF-dependent neuroprotection
(18). Therefore, we determined which of these pathways were
involved in PF-induced expression of LIF. The NF-kB pathway was
not activated by PF treatment (data not shown). Although all of the
MAPK pathways, including ERK, JNK, and p38, were activated by PF,
only the JNK and p38 pathways were involved in the PF-stimulated
expression of LIF (Fig. 3). Furthermore, the PF-induced expression
of LIFR was regulated by JNK, p38, and ERK pathways (Fig. S1).
These data suggested that PF regulated the expression of LIF and
LIFR expressions via different signaling pathways. Knocking down
LIF expression or blocking LIFR function decreased the adhesionbetween trophoblastic JAr cells and endometrial Ishikawa cells
(Fig. 4). These results clearly demonstrate that PF-induced endo-
metrial receptivity was directly mediated by increased expression
of LIF and by the function of LIFR.
For successful embryo implantation, the interaction between LIF
and LIFR must activate the signal transducer and activator of
transcription 3 (STAT3), which consequently enhances the
expression of adhesion molecules, such as integrin aVb3 and aVb5
(29). In addition, integrin aVb3 and aVb5 have the motif for
cellecell adhesion that act as receptors for the arginine-glycine-
aspartic acid (RGD) domain which is essential in embryo implan-
tation (29,30). Our results also revealed that PF treatment increased
the expression of integrin b3 and integrin b5, but the expression of
integrin aVwas not changed. Treatment with hLA revealed that the
expression of integrin b3 and b5 was mediated by LIF expression.
Furthermore, inhibition of integrin b3 and b5 using neutralizing
antibodies successfully blocked the PF-induced adhesion between
JAr and Ishikawa cells (Fig. 5). We previously demonstrated that the
expression of integrin b3 and b5 are crucial for the LIF-mediated
adhesion of trophoblast and endometrial cells (29). These ﬁnd-
ings suggest that PF enhances endometrial receptivity through the
expression of integrin b3 and b5 in an LIF-dependent manner
(Fig. 6).
Fig. 5. Antagonist for LIF-R inhibits LIF-induced expression of adhesion molecules in Ishikawa cells. (A, B) Ishikawa cells were treated with hLA (50 ng/mL) for 1 h, and then
treated with PF (50 mg/mL) for 24 h. The mRNA (A) and protein expressions (B) of adhesion molecules were analyzed by western blotting and RT-PCR, respectively. Band intensity
was calculated by fold of control and shown as mean ± SD of three independent experiments. *p < 0.05, **p < 0.01, and ***p < 0.001 in comparison with control group (1st lane).
##p < 0.01 and ###p < 0.001 in comparison with PF-treated group (2nd lane). (C) Ishikawa cells were pre-treated with neutralizing antibodies against integrin b3 or b5 for 1 h, and
then treated with PF (50 mg/mL). Isotype IgG was used for the control. Fluorescence labeled-JAr cells were applied to the adhesion assay. Attached JAr cells were counted, calculated
as percentage of control, and shown as mean ± SD. ***p < 0.001 in comparison with control group (1st lane) and ###p < 0.001 in comparison with PF-treated group (2nd lane).
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ovulation, fertilization, fertilized egg development, and embryo
transport, were improved by the development of ARTs (31). How-
ever, the imperfection of implantation was not solved by ARTs or
other medications, and it remains an unmet need clinically. Thus,
several studies using therapeutic manipulation of traditional
medicine, such as acupuncture and herbal remedies, were per-
formed to improve implantation rates (7,8). Based on results fromFig. 6. Schematic representation of the molecular mechanism underlying PF-
stimulated endometrial receptivity. PF enhances LIF expression through activation
of JNK and p38 pathways. Increased LIF expression stimulates endometrial receptivity
toward trophoblast via increasing the expression of ITGB3 and ITGB5.these studies and ours, herbal medicines can be a good alternative
option for increasing endometrial receptivity. Additional extensive
studies are necessary to identify the active compounds of PF, from
the known ingredients of PF, such as protocatechuic acid, ferulic
acid, rosmarinic acid, and coumaric acid, or unknown compounds.
In addition, it is also needed to establish the in vivo efﬁcacy of PF.
In conclusion, PF induced the expression of LIF and LIFR through
JNK and p38 signaling pathways in endometrium Ishikawa cells. In
addition, PF-induced LIF expression increased the attachment of
trophoblastic JAr cells to endometrial Ishikawa cells. This adhesion
was mediated by the expression of integrin b5 and b3. Taken
together, our results suggest that PF is a promising candidate for the
development of novel and effective medicines to help female pa-
tients suffering from a defect in implantation.
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